{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:34:40Z","timestamp":1790674480491,"version":"4.1.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/fpc.0b013e328356fa90","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T02:53:53Z","timestamp":1349060033000},"page":"765-776","source":"Crossref","is-referenced-by-count":30,"title":["Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression"],"prefix":"10.1097","volume":"22","author":[{"given":"Karim","family":"Malki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbarasu","family":"Lourdusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Pay\u00e1-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Sluyter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Keers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McGuffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Uher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard C.","family":"Schalkwyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210213","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-0327(94)90041-8","article-title":"A brief self-report depression measure assessing mood state and social impairment.","volume":"30","author":"Parker","year":"1994","journal-title":"J Affect Disord"},{"key":"R2-1-20210213","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archpsyc.65.5.513","article-title":"Population-based study of first onset and chronicity in major depressive disorder.","volume":"65","author":"Eaton","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R3-1-20210213","first-page":"43","article-title":"Health-related quality of life in depression: a STARD report.","volume":"22","author":"Daly","year":"2010","journal-title":"Ann Clin Psychiatry"},{"key":"R4-1-20210213","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jad.2009.04.026","article-title":"Health related quality of life in recurrent depression: a comparison with a general population sample.","volume":"120","author":"Ten Doesschate","year":"2010","journal-title":"J Affect Disord"},{"key":"R5-1-20210213","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1017\/S0033291710000164","article-title":"Impact of severity and type of depression on quality of life in cases identified in the community.","volume":"40","author":"Nuevo","year":"2010","journal-title":"Psychol Med"},{"key":"R6-1-20210213","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2009.09.001","article-title":"History of suicide attempts among patients with depression in the GENDEP project.","volume":"123","author":"Perroud","year":"2010","journal-title":"J Affect Disord"},{"key":"R7-1-20210213","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jad.2010.04.032","article-title":"Explained factors of suicide attempts in major depression.","volume":"127","author":"Hantouche","year":"2010","journal-title":"J Affect Disord"},{"key":"R8-1-20210213","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1017\/S0033291702006943","article-title":"Psychological autopsy studies of suicide: a systematic review.","volume":"33","author":"Cavanagh","year":"2003","journal-title":"Psychol Med"},{"key":"R9-1-20210213","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.91.4.999","article-title":"Depression and 18-month prognosis after myocardial infarction.","volume":"91","author":"Frasure-Smith","year":"1995","journal-title":"Circulation"},{"key":"R10-1-20210213","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9149(90)90736-K","article-title":"Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS).","volume":"66","author":"Ahern","year":"1990","journal-title":"Am J Cardiol"},{"issue":"Pt 1","key":"R11-1-20210213","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-8703(99)70159-6","article-title":"Relation between myocardial infarction, depression, hostility, and death.","volume":"138","author":"Kaufmann","year":"1999","journal-title":"Am Heart J"},{"key":"R12-1-20210213","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4088\/JCP.08m04765blu","article-title":"Type D personality predicts clinical events after myocardial infarction, above and beyond disease severity and depression.","volume":"71","author":"Martens","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R13-1-20210213","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S0033291709990997","article-title":"Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis.","volume":"40","author":"Martens","year":"2010","journal-title":"Psychol Med"},{"key":"R14-1-20210213","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2753.2010.01446.x","article-title":"Depression and self-reported functional status: impact on mortality following acute myocardial infarction.","volume":"17","author":"Kurdyak","year":"2011","journal-title":"J Eval Clin Pract"},{"key":"R15-1-20210213","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9149(96)00380-3","article-title":"Depression and long-term mortality risk in patients with coronary artery disease.","volume":"78","author":"Barefoot","year":"1996","journal-title":"Am J Cardiol"},{"key":"R16-1-20210213","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","article-title":"The global burden of disease, 1990-2020.","volume":"4","author":"Lopez","year":"1998","journal-title":"Nat Med"},{"key":"R17-1-20210213","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/archinte.160.21.3278","article-title":"Depression and diabetes: impact of depressive symptoms on adherence, function, and costs.","volume":"160","author":"Ciechanowski","year":"2000","journal-title":"Arch Intern Med"},{"key":"R19-1-20210213","first-page":"405","article-title":"The economic burden of depression in 1990.","volume":"54","author":"Greenberg","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"R20-1-20210213","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1192\/bjp.bp.108.051193","article-title":"Why do antidepressants take so long to work A cognitive neuropsychological model of antidepressant drug action.","volume":"195","author":"Harmer","year":"2009","journal-title":"Br J Psychiatry"},{"key":"R21-1-20210213","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression.","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"R22-1-20210213","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression.","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"R23-1-20210213","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","article-title":"Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.","volume":"178","author":"Thase","year":"2001","journal-title":"Br J Psychiatry"},{"issue":"Suppl 1","key":"R25-1-20210213","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jad.2009.06.041","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.","volume":"117","author":"Lam","year":"2009","journal-title":"J Affect Disord"},{"key":"R26-1-20210213","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4088\/JCP.v67n1203","article-title":"Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.","volume":"67","author":"Ruhe","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 18","key":"R27-1-20210213","first-page":"12","article-title":"Switching antidepressants for treatment-resistant major depression.","volume":"62","author":"Marangell","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R28-1-20210213","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression.","volume":"354","author":"Trivedi","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R29-1-20210213","first-page":"26","article-title":"New approaches to the treatment of refractory depression.","volume":"61","author":"Fava","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 6","key":"R30-1-20210213","first-page":"27","article-title":"Major depressive disorder: remission of associated symptoms.","volume":"67","author":"Trivedi","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R31-1-20210213","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1196\/annals.1369.004","article-title":"Gene expression in the brain from fluoxetine-injected mouse using DNA microarray.","volume":"1074","author":"Takahashi","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"R32-1-20210213","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/87865","article-title":"The cellular neurobiology of depression.","volume":"7","author":"Manji","year":"2001","journal-title":"Nat Med"},{"key":"R33-1-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psc.2006.12.005","article-title":"The molecular neurobiology of depression.","volume":"30","author":"Shelton","year":"2007","journal-title":"Psychiatr Clin North Am"},{"key":"R34-1-20210213","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/(SICI)1098-1128(200005)20:3<216::AID-MED6>3.0.CO;2-0","article-title":"Mouse geneticsgenomics: an effective approach for drug target discovery and validation.","volume":"20","author":"West","year":"2000","journal-title":"Med Res Rev"},{"key":"R35-1-20210213","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2105-8-132","article-title":"A verification protocol for the probe sequences of Affymetrix genome arrays reveals high probe accuracy for studies in mouse, human and rat.","volume":"8","author":"Alberts","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"R36-1-20210213","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.biopsych.2010.08.011","article-title":"Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants.","volume":"69","author":"Malki","year":"2011","journal-title":"Biol Psychiatry"},{"key":"R37-1-20210213","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1192\/bjp.bp.108.057554","article-title":"Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.","volume":"194","author":"Uher","year":"2009","journal-title":"Br J Psychiatry"},{"key":"R38-1-20210213","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/da.20051","article-title":"Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting.","volume":"21","author":"Rush","year":"2005","journal-title":"Depress Anxiety"},{"key":"R39-1-20210213","first-page":"59","article-title":"Escitalopram in clinical practice: results of an observational study in patients with depression and anxiety.","volume":"18","author":"Holsboer-Trachsler","year":"2011","journal-title":"Psychopharmakotherap"},{"key":"R40-1-20210213","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1741-7015-7-60","article-title":"Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial.","volume":"7","author":"Perroud","year":"2009","journal-title":"BMC Med"},{"key":"R41-1-20210213","first-page":"62","article-title":"Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression - a clinical-study.","volume":"52","author":"Fabre","year":"1991","journal-title":"J Clin Psychiat"},{"key":"R42-1-20210213","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/FPC.0b013e32834b3f35","article-title":"Antidepressants and the resilience to early-life stress in inbred mouse strains.","volume":"21","author":"Binder","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"R43-1-20210213","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data.","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"R44-1-20210213","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/bioinformatics\/btl476","article-title":"RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis.","volume":"22","author":"Hong","year":"2006","journal-title":"Bioinformatics"},{"key":"R45-1-20210213","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.","volume":"20","author":"Duman","year":"2000","journal-title":"J Neurosci"},{"key":"R46-1-20210213","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ajmg.b.30665","article-title":"No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: results of the depression case control (DeCC) study and a meta-analysis.","volume":"147B","author":"Gaysina","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R47-1-20210213","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/npp.2008.76","article-title":"Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal.","volume":"34","author":"Sibille","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"R48-1-20210213","first-page":"193S","article-title":"Sequence Variability in ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1, NTRK2 and BDNF: novel variations and association with depression and antidepressant response.","volume":"67","author":"Licinio","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R49-1-20210213","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/mp.2009.92","article-title":"Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.","volume":"14","author":"Licinio","year":"2009","journal-title":"Mol Psychiatry"},{"key":"R50-1-20210213","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nn.2257","article-title":"CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits.","volume":"12","author":"Wallace","year":"2009","journal-title":"Nat Neurosci"},{"key":"R51-1-20210213","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1248\/bpb.34.260","article-title":"Intravenous injection of neural progenitor cells improves cerebral ischemia-induced learning dysfunction.","volume":"34","author":"Mochizuki","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"R52-1-20210213","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.biopsych.2005.11.003","article-title":"The role of CREB in depression and antidepressant treatment.","volume":"59","author":"Blendy","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R53-1-20210213","first-page":"49","article-title":"Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models.","volume":"1","author":"Andrus","year":"2010","journal-title":"Mol Psychiatry"},{"key":"R54-1-20210213","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/npp.2008.76","article-title":"Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal.","volume":"34","author":"Surget","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"R55-1-20210213","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression.","volume":"67","author":"Lanctot","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R57-1-20210213","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0006-8993(96)00526-4","article-title":"Spontaneous circadian and light-induced expression of junB mRNA in the hamster suprachiasmatic nucleus.","volume":"732","author":"Guido","year":"1996","journal-title":"Brain Res"},{"key":"R58-1-20210213","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2119\/2008-00053.Begemann","article-title":"Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches.","volume":"14","author":"Ehrenreich","year":"2008","journal-title":"Mol Med"},{"key":"R59-1-20210213","doi-asserted-by":"crossref","first-page":"14011","DOI":"10.1074\/jbc.M901310200","article-title":"14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria.","volume":"284","author":"Wang","year":"2009","journal-title":"J Biol Chem"},{"key":"R60-1-20210213","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.pharmtox.47.120505.105242","article-title":"The functional impact of SLC6 transporter genetic variation.","volume":"47","author":"Hahn","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R61-1-20210213","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","article-title":"Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.","volume":"22","author":"Hope","year":"2002","journal-title":"J Neurosci"},{"key":"R62-1-20210213","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.296.13.1609","article-title":"Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression.","volume":"296","author":"Kim","year":"2006","journal-title":"JAMA"},{"key":"R63-1-20210213","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/mp.2008.32","article-title":"Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression.","volume":"13","author":"Weinberger","year":"2008","journal-title":"Mol Psychiatry"},{"key":"R64-1-20210213","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1601-1848.2003.00049.x","article-title":"Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders.","volume":"2","author":"Murphy","year":"2003","journal-title":"Genes Brain Behav"},{"key":"R65-1-20210213","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/jnr.20410","article-title":"Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice.","volume":"79","author":"Ren-Patterson","year":"2005","journal-title":"J Neurosci Res"},{"key":"R66-1-20210213","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.biopsych.2008.02.005","article-title":"Linkage disequilibrium mapping of a chromosome 15q25-26 major depression linkage region and sequencing of NTRK3.","volume":"63","author":"Potash","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R68-1-20210213","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.biopsych.2010.11.019","article-title":"The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions.","volume":"69","author":"Juhasz","year":"2011","journal-title":"Biol Psychiatry"},{"key":"R69-1-20210213","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(98)01010-5","article-title":"Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone.","volume":"813","author":"Schaaf","year":"1998","journal-title":"Brain Res"},{"key":"R70-1-20210213","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1523\/JNEUROSCI.0237-07.2007","article-title":"Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates.","volume":"27","author":"Perera","year":"2007","journal-title":"J Neurosci"},{"key":"R71-1-20210213","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.","volume":"15","author":"Nibuya","year":"1995","journal-title":"J Neurosci"},{"key":"R72-1-20210213","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hipo.20156","article-title":"Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment.","volume":"16","author":"Warner-Schmidt","year":"2006","journal-title":"Hippocampus"},{"key":"R73-1-20210213","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"R75-1-20210213","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","article-title":"The ascent of mouse: advances in modelling human depression and anxiety.","volume":"4","author":"Cryan","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"R76-1-20210213","doi-asserted-by":"crossref","first-page":"e6585","DOI":"10.1371\/journal.pone.0006585","article-title":"Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression.","volume":"4","author":"Sequeira","year":"2009","journal-title":"PLoS One"},{"key":"R77-1-20210213","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.neuron.2011.06.011","article-title":"Selective p38alpha MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction.","volume":"71","author":"Bruchas","year":"2011","journal-title":"Neuron"},{"issue":"Pt 18","key":"R78-1-20210213","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1113\/jphysiol.2008.155143","article-title":"Serotonin facilitates long-term depression induction in prefrontal cortex via p38 MAPKRab5-mediated enhancement of AMPA receptor internalization.","volume":"586","author":"Zhong","year":"2008","journal-title":"J Physioly"},{"key":"R79-1-20210213","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders.","volume":"59","author":"Duman","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R80-1-20210213","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nurx.2005.12.009","article-title":"Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets.","volume":"3","author":"Carlson","year":"2006","journal-title":"NeuroRx"},{"key":"R81-1-20210213","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tins.2005.06.005","article-title":"The many faces of CREB.","volume":"28","author":"Carlezon","year":"2005","journal-title":"Trends Neurosci"},{"key":"R82-1-20210213","first-page":"15S","article-title":"Cyclic-AMP response element-binding protein and brain-derived neurotrophic factor in mood disorders.","volume":"69","author":"Pandey","year":"2011","journal-title":"Biol Psychiatry"},{"key":"R84-1-20210213","doi-asserted-by":"crossref","first-page":"e20567","DOI":"10.1371\/journal.pone.0020567","article-title":"Antidepressant drugs transactivate TrkB neurotrophin receptors in the adult rodent brain independently of BDNF and monoamine transporter blockade.","volume":"6","author":"Rantamaki","year":"2011","journal-title":"PLoS One"},{"key":"R85-1-20210213","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1172\/JCI43992","article-title":"Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice.","volume":"121","author":"Cazorla","year":"2011","journal-title":"J Clin Invest"},{"key":"R86-1-20210213","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1523\/JNEUROSCI.23-01-00349.2003","article-title":"Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects.","volume":"23","author":"Castren","year":"2003","journal-title":"J Neurosci"},{"key":"R87-1-20210213","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of Bdnf and Trkb messenger-Rna in rat-brain by chronic electroconvulsive seizure and antidepressant drug treatments.","volume":"15","author":"Nibuya","year":"1995","journal-title":"J Neurosci"},{"key":"R88-1-20210213","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2006.12.008","article-title":"Proteomic analysis of rat cortical neurons after fluoxetine treatment.","volume":"1135","author":"Cecconi","year":"2007","journal-title":"Brain Res"},{"key":"R89-1-20210213","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2004.10.047","article-title":"Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells.","volume":"374","author":"Baik","year":"2005","journal-title":"Neurosci Lett"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0b013e328356fa90","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:27:21Z","timestamp":1620952041000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201211000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e328356fa90","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}